| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2883470 | The Annals of Thoracic Surgery | 2006 | 6 Pages |
Abstract
The adaptation of commercially available stent-graft devices to treat TTAT is technically feasible, and can be performed with low rates of morbidity and mortality. The long-term durability of endovascular repair of TTAT remains unknown, but early and midterm results appear promising.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hassan Y. MB, ChB, Brian G. MD, Kushagra MD, Mark D. MD, Randy MD, Gabrielle MD, Tomas MD, Giuseppe RT, Darwin MD, Mark K. MD,